PRODUCT LITERATURE

N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease

---

To develop an efficient therapy for chronic obstructive pulmonary disease (COPD), N-acetylcysteine (NAC) has been tested as a medication that can suppress various pathogenic processes in this disease. NAC is a thiol compound, which provides sulfhydryl groups. NAC can act as a precursor of reduced glutathione and as a direct reactive oxygen species scavenger, hence regulating the redox status in the cells.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Respicyl

Specific Detail Info

Ther Adv Respir Dis (2012) 6(3) 127–135

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment